http://www.aeriepharma.com
Aerie Pharmaceuticals, Inc. Company Intro
Aerie Pharmaceuticals, a leading ophthalmic pharmaceuticals company conducting R&D of products for treating patients with glaucoma and other eye diseases.
Industry
Healthcare
Aerie Pharmaceuticals, Inc. Headquaters
4301 Emperor Boulevard
Durham,27703
United States
Aerie Pharmaceuticals, Inc. Share price
14 Sep 2022 08:32 GMT
$15.12
-0.02 (-0.13 %)
Aerie Pharmaceuticals, Inc. Market cap
$748.108 M
WMC RANKING
2023
Aerie Pharmaceuticals, Inc. # 41
Drug Manufacturers—Specialty & GenericLatest Aerie Pharmaceuticals, Inc. News
30 Jan 2023
Age Related Vision Dysfunction Market is expected to reach ...
Aerie Pharmaceuticals; Santen Pharmaceutical; Sun Pharma Advanced Research ... In May 2020, AbbVie Inc. finalised the strategic acquisition of Allergan plc.
30 Jan 2023
Age Related Vision Dysfunction Market is expected to reach ...
Aerie Pharmaceuticals; Santen Pharmaceutical; Sun Pharma Advanced Research ... In May 2020, AbbVie Inc. finalised the strategic acquisition of Allergan plc.
30 Jan 2023
Age Related Vision Dysfunction Market is expected to reach ...
Aerie Pharmaceuticals; Santen Pharmaceutical; Sun Pharma Advanced Research ... In May 2020, AbbVie Inc. finalised the strategic acquisition of Allergan plc.
WMC Market Score
WMC Market to Revenue Score
Aerie Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Aerie Pharmaceuticals, Inc. | USD | $85,767 | $205,795 | $-175,936 | $7,481M | 41 |
| Teva Pharmaceutical Industries Limited | USD | $16,283,000 | $4,659,000 | $-3,982,000 | $99,380B | 1 |
| Bausch Health Companies Inc. | USD | $8,042,000 | $4,348,001 | $-1,018,000 | $26,650B | 2 |
| Zoetis Inc. | USD | $7,012,000 | $2,380,000 | $1,774,000 | $761,690B | 3 |
| Perrigo Company plc | USD | $4,990,000 | $1,357,500 | $-230,900 | $52,610B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Aerie Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Aerie Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Aerie Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Aerie Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Aerie Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Aerie Pharmaceuticals, Inc. | 0.53 | 0 | 0 | 0 | 0 | 0 | 0 |
| Teva Pharmaceutical Industries Limited | 100 | 3.55 | 2.31 | 59 | 0 | 0 | 23.57 |
| Bausch Health Companies Inc. | 49.39 | 1.02 | 47.07 | 100 | 0 | 0 | 53.97 |
| Zoetis Inc. | 43.06 | 100 | 100 | 74 | 0 | 0 | 100 |
| Perrigo Company plc | 30.65 | 4.61 | 3.01 | 83 | 0 | 0 | 32.94 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
